FORMULATION AND EVALUATION NANOEMULGEL FOR OSTEOARTHRITIS USING BOSWELLIA SERRATA AND WITHANIA SOMNIFERA

This research proposal revolves around the formulation and evaluation of nanoemulgels containing extracts from Boswellia serrata and Withania somnifera, traditional medicinal plants known for their anti-inflammatory properties. The specific focus is to develop a viable therapeutic agent that may hold potential in the treatment and management of osteoarthritis. The scientific approach integrates pharmaceutical formulation, advanced characterization techniques, and in vitro testing methods, paving the way for an innovative treatment paradigm that fuses traditional wisdom with modern pharmaceutical science. This study represents an integrative effort to harness the therapeutic potential of these botanical extracts, applying state-of-the-art nanotechnology to maximize their bioavailability and efficacy. It signifies a novel endeavor to address the debilitating condition of osteoarthritis, which affects millions of individuals worldwide.